Argentiero, Antonella Solimando, Antonio Giovanni Ungaro, Valentina Laforgia, Mariarita Strippoli, Sabino Pinto, Dario Negri, Antonio Ferraiuolo, Simona Zito, Alfredo Guida, Michele
...
Published in
Frontiers in Oncology
Recent advances in tumor immunotherapy have made it possible to efficiently unleash immune effectors, reacting against neoplastic cells. Although these approaches primarily aim to eradicate malignancy, immune-related adverse events (irAEs) often influence patients’ prognosis, constituting a new spectrum of side effects. Taking into account the typi...
Kutara, Kenji Mochizuki, Yohei Ohnishi, Akihiro Mitsui, Ikki Kanda, Teppei Sugiyama, Akihiko Maeta, Noritaka Kobayashi, Kosuke Shimizu, Yuki Okamura, Yasuhiko
...
Published in
Veterinary Sciences
A 9-year-old male intact domestic cat weighing 4.6 kg was referred for tachypnea. A large mass was visible in computed tomography (CT) scans of the thoracic cavity. A histopathological evaluation of the mass was consistent with thymoma. The cat was treated with 2 × 8 Gy intensity modulated radiation therapy and sulfoquinovosyl acyl propanediol (SQA...
Prosch, Helmut Röhrich, Sebastian Tekin, Zeynep Nilufer Ebner, Lukas
Published in
Journal of Thoracic Disease
Tumors in the prevascular compartment of the mediastinum are rare and imaging plays a major role in their detection, (differential) diagnosis, staging, and follow-up. The prevascular compartment is bordered anteriorly by the posterior aspect of the sternum, posteriorly by the ventral aspect of the pericardium, cranially by the thoracic outlet, and ...
Jakopovic, Marko Bitar, Lela Seiwerth, Fran Marusic, Ante Krpina, Kristina Samarzija, Miroslav
Published in
Journal of Thoracic Disease
Thymic epithelial tumors (TETs) are rare thymic neoplasms. There are approximately 1.5 cases per million TETs per year. They are the most common anterior mediastinal tumors in adults. Due to limited activity of available treatment options novel strategies and treatment options are needed and treatment with immune checkpoint inhibitors is an attract...
Jovanovic, Dragana Markovic, Jelena Ceriman, Vesna Peric, Jelena Pavlovic, Sonja Soldatovic, Ivan
Published in
Journal of Thoracic Disease
Thymic epithelial tumors (TETs) include several anterior mediastinal malignant tumours: thymomas, thymic carcinomas and thymic neuroendocrine cancers. There is significant variety in the biologic features and clinical course of TETs and many attempts have been made to identify target genes for successful therapy of TETs. Next generation sequencing ...
Qiu, Guanghao Wang, Fuqiang Zhang, Hanlu Zheng, Yu Wang, Zihao Wang, Yun
Published in
Journal of Thoracic Disease
Bibliometric analysis can help us analyse the most influential papers, authors, research institutions in a discipline or topic and analyse the impact of these papers on a specific field. Our purpose is to identify the 100 most cited papers about thymic epithelial tumours (TETs) and analyse their key characteristics. We use certain search terms in t...
Morfouace, Marie Stevovic, Aleksandra Vinches, Marie Golfinopoulos, Vassilis Jin, Dexter X. Holmes, Oliver Erlich, Rachel Fayette, Jerome Croce, Sabrina Ray-Coquard, Isabelle
...
Published in
ESMO Open
Purpose Rare cancers are defined by an incidence of
Tateo, Valentina Manuzzi, Lisa De Giglio, Andrea Parisi, Claudia Lamberti, Giuseppe Campana, Davide Pantaleo, Maria Abbondanza
Published in
International journal of molecular sciences
Thymic epithelial tumors (TETs) are a group of rare thoracic malignancies, including thymic carcinomas (TC) and thymomas (Tm). Autoimmune paraneoplastic diseases are often observed in TETs, especially Tms. To date, chemotherapy is still the standard treatment for advanced disease. Unfortunately, few therapeutic options are available for relapsed/re...
Zhai, Yirui Wei, Yong Hui, Zhouguang Gao, Yushun Luo, Yang Zhou, Zongmei Feng, Qinfu Li, Yuemin
Published in
Frontiers in Oncology
Objective The association between the prognosis of thymoma and MG remains controversial. Differences in clinical characteristics and treatments between patients with and without MG may affect the findings of those studies. We designed this propensity score matching trial to investigate whether MG is an independent prognostic predictor in thymoma. M...
De Rosa, Anna Fornili, Marco Maestri Tassoni, Michelangelo Guida, Melania Baglietto, Laura Petrucci, Loredana Chella, Antonio Melfi, Franca Lucchi, Marco Ricciardi, Roberta
...
Published in
Thoracic Cancer
In our paper, we retrospectively analyzed the changes in antiacetylcholine receptor antibody (AChR‐Ab) titer before and after thymectomy and the clinical features of thymoma‐associated myasthenia gravis (TAMG) patients in order to identify clinical and serological predictors of thymoma recurrence. Our study emphasizes the importance of a multidisci...
